INO:NASDAQ
Inovio Pharmaceuticals Inc
US$ 1.43
0.00%
(0.00) Siku 1
US$ 1.42
arrow_downward
-0.70% (-0.0100)todayKabla ya soko
Imefungwa: 13 Nov, 16:00:01 GMT -5 · USD
search
Alama zote
| Alama | Bei | Tofauti | Tofauti ya asilimia |
|---|
insights_autoInatayarisha maarifa maarufu ya INO...
Mtaji wa soko
267.85M
Wastani wa kiasi cha mauzo
19.34M
Kiasi cha mauzo ya hisa
elfu 96.00
Juu kwa wiki 52
US$ 2.72
Chini kwa wiki 52
US$ 0.56
EPS
-US$ 0.80
Beta
1.71
Hisa za wawekezaji
187.31M
Idadi ya wafanyakazi
112
Mtaji wa soko
267.85M
Wastani wa kiasi cha mauzo
19.34M
Kiasi cha mauzo ya hisa
elfu 96.00
Juu kwa wiki 52
US$ 2.72
Chini kwa wiki 52
US$ 0.56
EPS
-US$ 0.80
Beta
1.71
Hisa za wawekezaji
187.31M
Idadi ya wafanyakazi
112
Habari
Kutoka kwenye vyanzo vya wavuti na washirika wa habari
StreetInsider
·
dakika 8 zilizopita
S&P 500, Nasdaq set for lower open as AI stocks feel Nvidia heat
Barron's
·
saa 1 iliyopita
S&P 500 Futures Fall in Premarket Trading; TELUS Corp., Vaxcyte Lead
Investing.com
·
saa 1 iliyopita
Barclays joins Morgan Stanley in seeing S&P 500 at 8,700 by end-2027
FXEmpire
·
dakika 46 zilizopita
Why The S&P 500 Could Fall 63% – And Still Only Be Fairly Valued
Wasifu
Inovio Pharmaceuticals, Inc. is an American biotechnology company focused on the discovery, development, and commercialization of synthetic DNA products for treating cancers and infectious diseases. In April 2020, Inovio was among some 100 companies, academic centers, or research organizations developing a vaccine candidate for treating people infected with COVID-19, with more than 170 total vaccine candidates in development. Wikipedia
Kuhusu Inovio Pharmaceuticals Inc
Afisa Mkuu Mtendaji (CEO)Jacqueline Shea
Wafanyakazi112
Lilianzishwa1999
Makao makuu-
SektaHealth Care
Sekta-
Tovutiinovio.com